Se ha denunciado esta presentación.
Se está descargando tu SlideShare. ×

2014 06-05 slot-9 00_passarani - london

Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Cargando en…3
×

Eche un vistazo a continuación

1 de 18 Anuncio
Anuncio

Más Contenido Relacionado

Presentaciones para usted (20)

Similares a 2014 06-05 slot-9 00_passarani - london (20)

Anuncio

Más reciente (20)

2014 06-05 slot-9 00_passarani - london

  1. 1. Developing an environment for change Ilaria Passarani Head of the Food and Health Department 50th AESGP Annual Meeting 18th WSMI General Assembly London 5 June 2014
  2. 2. The consumer perspective
  3. 3. Behavior change pathway
  4. 4. Know me My life is complicated: many products, many brands, many supply channels I’m overloaded with info : many channels, many sources I’m demanding,analytic/lazy,em powered/ vulnerable I’m super social / not IT savy I want to be more involved in the decisions about my health but need the tools to do so I have to take a more active
  5. 5. What I want from self-medication - Will work for me - Does not have many side effects - Will be as effective as a prescription - I can afford it
  6. 6. Connect me
  7. 7.  97,000 mHealth apps are currently available across multiple platforms on the global market  approximately 70% of mHealth apps target the consumer wellness and fitness segments, 30% of apps target health professionals, easing access to patient data,diagnostic imaging, pharmaceuticals information etc  by 2017 3.4 billion people worldwide will own a smartphone and half of them will be using mHealth apps  23% of consumers have used any sort of mHealth solution  67% said they would like to do “nothing at all” on their mobile phone in support of their health  77% had never used their phone for health-related activities  45% of consumers say they are concerned about the unwanted use of their data when using mobile devices for health-related activities European Commission, April 2014 mHEALTH
  8. 8. Health information through social media
  9. 9. Getting social: challenges and opportunities
  10. 10. Key principles  Give consumers a secure digital environment data protection  Maintain a clear distinction between information and advertising  The source of the information/ the “sponsor” of the advertising should always be clearly indicated  Maintain a clear distinction between different sources of information (e.g. competent authorities, health care professionals, companies)
  11. 11. High quality information l  objective and unbiased  consumer friendly  evidence-based  up to date  reliable  understandable  accessible  transparent  relevant and appropriate  non promotional  objective and unbiased  consumer friendly  evidence-based  up to date  reliable  understandable  accessible  transparent  relevant and appropriate  non promotional  consumers’ empowerment  compliance and adherence to treatments  patient safety  health outcomes  consumers’ empowerment  compliance and adherence to treatments  patient safety  health outcomes
  12. 12. Empower me HLS – EU Consortium, 2012
  13. 13. Guide me  More information is not enough. Consumers need the tools to interprete it and support from health care professionals  Healthcare professionals: from decision makers to advisers
  14. 14. Consumers’ expectations from pharmacists  Honest and credible  Objective , unbiased and proactive advice  Clear and consumer friendly  Comparative information  More questions and more answers  More active role in the detection of possible interactions  Continued training and quality controls
  15. 15. Symplify it for me  BETTER LABELLING • Less medical jargon and more straight forward language • Better use of simple design techniques (ex. bullet points, paragraphs, short sentences) • Clearer safety information, including standardized frequency indications • Larger print • More visible expiration date and storage information • More pictures and pictograms • No repetitions  MORE CONSISTENT CLASSIFICATION OF BORDERLINE PRODUCTS ( OTC, medical devices, herbal medicines, food supplements)  ALLOW CONSUMERS TO MAKE EASY AND MEANINGFUL CHOICES
  16. 16. Cooperation among stakeholders  Stakeholders involvement in regulatory decisions EMA  European Commission Process on Corporate Responsibility in the field of pharmaceuticals Working Group on Promoting good governance of non-prescription drugs
  17. 17. Promoting safe and responsible self care • Address complexity • Promote informed choices • Investments in IT and health literacy • Incentives • Coordinated efforts • Trust, ethics and transparency • Adapt to the new consumer changing needs
  18. 18. www.beuc.eu – health@beuc.eu Thank you

×